Beta-blocker with alpha-1 blocking activity

This page covers all Beta-blocker with alpha-1 blocking activity drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Alpha-1 adrenergic receptor.

Targets

Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Alpha-1 adrenergic receptor

Marketed (1)

• CarVeDilol-SR (Slow Release) · Seoul National University Bundang Hospital · Cardiovascular
  Carvedilol is a non-selective beta-adrenergic receptor antagonist with alpha-1 blocking activity that reduces heart rate, blood pressure, and cardiac workload.

Phase 3 pipeline (3)

• Carvedilol Phosphate modified release formulation · GlaxoSmithKline · Cardiovascular
  Carvedilol is a non-selective beta-adrenergic receptor antagonist with alpha-1 blocking activity that reduces heart rate, blood pressure, and cardiac workload.
• Carvedilol SR 64mg, QD · Chong Kun Dang Pharmaceutical · Cardiovascular
  Carvedilol SR is a non-selective beta-blocker with alpha-1 blocking activity that reduces heart rate, blood pressure, and cardiac workload.
• Carvedilol SR 32mg, QD · Chong Kun Dang Pharmaceutical · Cardiovascular
  Carvedilol SR is a non-selective beta-blocker with alpha-1 blocking activity that reduces heart rate, blood pressure, and cardiac workload.